Anagliptin - CISMeF

Preferred Label : Anagliptin;

NCIt synonyms : Pyrazolo(1,5-a)pyrimidine-6-carboxamide, N-(2-((2-((2S)-2-cyano-1-pyrrolidinyl)-2-oxoethyl)amino)-2-methylpropyl)-2-methyl-;

NCIt definition : An orally available, potent, selective inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Compared to vildagliptin, anagliptin caused longer lasting inhibition of DPP-4 activity.;

UNII : K726J96838;

InChIKey : LDXYBEHACFJIEL-HNNXBMFYSA-N;

CAS number : 739366-20-2;

Chemical formula : C19H25N7O2;

Détails

Origin ID

C96202;

UMLS CUI

C3272640;

Currated CISMeF NLP mapping
- anagliptin [MeSH concept]
- anagliptin [MeSH Supplementary Concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- anagliptin [MeSH concept]
- anagliptin [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients